Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (07/19/2018)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Stage Information for Small Cell Lung Cancer (SCLC)

Updated staging information for 2017 (cited American Joint Committee on Cancer as reference 1).

Limited-Stage SCLC Treatment

Added text about the phase III CONVERT study (NCT00433563) (cited Faivre-Finn et al. as reference 21 and level of evidence 1iiA).

This summary is written and maintained by the PDQ Adult Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Recurrent SCLC Treatment

Next section >
About This PDQ Summary